Department of Food Biotechnology and Nutritional Sciences in School of Life Sciences, Nelson Mandela African Institution of Science and Technology, P. O. Box 477, Arusha, Tanzania.
Department of Food Technology, Nutrition and Consumer Sciences, Sokoine University of Agriculture, Morogoro, Tanzania.
BMC Pregnancy Childbirth. 2019 Aug 28;19(1):315. doi: 10.1186/s12884-019-2463-8.
Hyperglycemia in pregnancy is a medical condition resulting from either pre-existing diabetes or insulin resistance developed during pregnancy. This study aimed to determine the prevalence of hyperglycemia in pregnancy and influence of body fat percentage and other determinants on developing hyperglycemia in pregnancy among women in Arusha District, Tanzania.
A cross-sectional study was conducted between March and December 2018 at selected health facilities in Arusha District involving 468 pregnant women who were not known to have diabetes before pregnancy. Blood glucose was tested by Gluco-Plus™ using the World Health Organization criteria at fasting and 2 h after consuming 75 g of glucose dissolved in 300 ml of water. Body fat was measured using a bioelectric impedance analyzer, mid-upper arm circumference using a regulated tape, weight using SECA™, blood pressure using a GT-868UF Geratherm™ machine, and height using a stadiometer. Demographic and maternal characteristics were collected through face to face interviews using a structured questionnaire.
The participants' mean age was 28 years (SD ± 6), mid-upper arm circumference 27 cm (SD ± 3.7), body fat 33.72% (SD ± 7.2) and pre-pregnancy body mass index 25.6 kg/m (SD ± 5.5). One-third of participants had mid-upper arm circumferences ≥28 cm with 25% being overweight and 22.7% obese before pregnancy. Prevalence of hyperglycemia in pregnancy was 16.2% (n = 76) of which 13% had gestational diabetes and 3.2% diabetes in pregnancy. Hyperglycemia in pregnancy was significantly associated with body fat percentage (AOR 1.33; 95% CI: 1.22-1.44), family history of Type 2 diabetes mellitus (AOR 6.95, 95% CI: 3.11-15.55), previous delivery of babies ≥4 kg (AOR 2.3, 95% CI: 1.00-5.28), mid-upper arm circumference ≥ 28 cm (AOR 1.2, 95% CI: 1.09-1.32), and Type 2 diabetes mellitus symptoms (AOR 2.83, 95% CI: 1.53-6.92).
The prevalence of hyperglycemia in pregnancy was high, particularly among women with history of delivering ≥4-kg babies, increased body fat, mid-upper arm circumference, symptoms and/or family history of Type 2 diabetes mellitus. These findings identify opportunities to further explore the utility of body fat percentage and other determinants for rapid screening and management of hyperglycemia in pregnancy.
妊娠性高血糖症是一种由妊娠期间发生的预先存在的糖尿病或胰岛素抵抗引起的医学病症。本研究旨在确定坦桑尼亚阿鲁沙地区孕妇妊娠性高血糖症的流行率,并确定体脂百分比和其他决定因素对妊娠性高血糖症发展的影响。
2018 年 3 月至 12 月在阿鲁沙区选定的卫生设施进行了一项横断面研究,涉及 468 名孕妇,这些孕妇在怀孕前没有被诊断患有糖尿病。使用 Gluco-Plus™ 根据世界卫生组织标准在空腹和饮用 300ml 溶解在 75g 葡萄糖后的 2 小时内检测血糖。使用生物电阻抗分析仪测量体脂,使用规定的胶带测量中臂围,使用 SECA™ 测量体重,使用 GT-868UF Geratherm™ 机器测量血压,使用测高仪测量身高。通过面对面访谈使用结构化问卷收集人口统计学和产妇特征。
参与者的平均年龄为 28 岁(标准差±6),中臂围 27cm(标准差±3.7),体脂 33.72%(标准差±7.2),孕前体重指数 25.6kg/m(标准差±5.5)。三分之一的参与者中臂围≥28cm,其中 25%超重,22.7%肥胖。妊娠性高血糖症的患病率为 16.2%(n=76),其中 13%患有妊娠期糖尿病,3.2%患有妊娠糖尿病。妊娠性高血糖症与体脂百分比(AOR 1.33;95%CI:1.22-1.44)、2 型糖尿病家族史(AOR 6.95,95%CI:3.11-15.55)、以前分娩的婴儿体重≥4kg(AOR 2.3,95%CI:1.00-5.28)、中臂围≥28cm(AOR 1.2,95%CI:1.09-1.32)和 2 型糖尿病症状(AOR 2.83,95%CI:1.53-6.92)显著相关。
妊娠性高血糖症的患病率很高,尤其是在有分娩≥4kg 婴儿、体脂增加、中臂围增加、症状和/或 2 型糖尿病家族史的妇女中。这些发现为进一步探索体脂百分比和其他决定因素在妊娠性高血糖症快速筛查和管理中的应用提供了机会。